Support Alert

Drug safety update: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients. It is now recommended that either the patient or their female partner use reliable contraception during treatment with mycophenolate medicines and for at least 90 days after stopping.
 


Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society

Loading...
Return To Top